Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00597766Phase 2Completed
Phase 2, randomised, double-blind trial of triamcinolone in shoulder pain (3 arms), sponsored by MetroHealth Medical Center. Primary endpoint: Brief Pain Inventory, Question 12 at 12 weeks. Started Dec 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00597766.